1.877.870.5610 | Contact | SiteMap
Thomas Godby was appointed to the Board of Directors in the fall of 2001 and later confirmed at the shareholders meeting on December 3, 2001. He serves as the Chairman of the Board of Directors. Mr. Godby, who is a native of Indianapolis, Indiana, has spent the majority of his business career in the mechanical contracting business. He was the founder and President of Godby Brothers, Inc., a mechanical contractor servicing central Indiana. Mr. Godby was also President of Godby Rental, a national provider of power distribution and mechanical services to the special event industry. He positioned his business for sale to American Residential Service Companies, a national business consolidator, in 1997. Mr. Godby is currently President of Godby Enterprises, a property management company, and President of Care Ambulance Company. Mr. Godby has a strong background in introducing and marketing new products and has been actively engaged in assisting early stage and start-up companies with development of business plans, obtaining financing, executive staffing, and business development. Mr. Godby serves on many boards of community service organizations in Central Indiana.
Robert S. Huffstodt
Robert S. Huffstodt joined the Company as Executive Vice President and Chief Financial Officer on July 17, 2001. Mr. Huffstodt was made President and Chief Operating Officer on October 2, 2001, and was made President and Chief Executive Officer in December 2002. Mr. Huffstodt is responsible for sales, marketing, finance, research and development and all operations related functions, including production. Most recently, Mr. Huffstodt was Executive Vice President and Chief Operating Officer for Quatro Systems, Inc. a leading electronics manufacturing services provider in the Southwest. At Quatro, Mr. Huffstodt was responsible for finance, production, sales and human resources. During Mr. Huffstodt’s tenure with Quatro, the size of the company doubled due to new contracts secured and the expansion of operations. Prior to joining Quatro, Mr. Huffstodt was President and Chief Executive Officer for Lukens Medical Corporation (NASDAQ:LUKN), a manufacturer of medical devices, primarily surgical sutures, lancets, and other disposables. Mr. Huffstodt served as CEO of Lukens from 1995 through 1998, during which time the company expanded globally, with manufacturing operations initiated in Mexico, Brazil and India. Distribution was also expanded to cover 44 countries, with several private branding arrangements put in place to address specific market segments. In 1996 the company acquired Ulster Scientific, a manufacturer of lancets and a distributor of diagnostic devices. In 1997, Lukens also acquired Pro-Tec Containers Inc, a manufacturer of sharps containers. Before serving as CEO, Mr. Huffstodt served as CFO of Lukens, and in that role was responsible for supporting the company’s initial public offering in 1992. Lukens was itself acquired in late 1998. Prior to Lukens, Mr. Huffstodt was a Certified Public Accountant, and worked for the Metropolitan Services Group, a division of Price Waterhouse located in New York City and focused on smaller businesses. Mr. Huffstodt holds a BBA in Accounting from the University of Notre Dame.
Joseph Broecker is a co-founder, Chairman, and Senior Managing Director of Periculum Capital Company, LLC and head of the firm's private equity and merchant banking practice. He was previously a Senior Vice President and Managing Director of Nat City Investments, Inc., as well as its predecessor firm, Raffensperger, Hughes and Co. Mr. Broecker focused most of his practice on private equity and expansion financings for emerging growth and technology-based companies. He co-founded two venture capital private equity partnerships and remains an active advisor to private equity firms throughout the Midwest. Mr. Broecker was a senior operating and corporate executive with a large European-based multi-national medical device and pharmaceutical company which involved the management of subsidiaries and divisions with an established market presence as well as new technology and start-up operations. Mr. Broecker was previously a manager in the consulting division of Ernst and Young (a/k/a Ernst & Ernst). He received an Executive MBA from Indiana University and a BBA in accounting and finance from the University of Notre Dame. Mr. Broecker is a CPA and has served as a director of a number of private and public companies primarily involved in the healthcare, chemical, and consumer industries.
Rollin M. Dick
Rollin M. Dick was appointed to the Board of Directors in the fall of 2001 and later confirmed at the shareholders meeting on December 3, 2001. Mr. Dick has 57 years of accounting and financial management experience. Since 2005 Mr. Dick has been a consultant with MH Equity Investors, an Indianapolis fund investing in and managing various businesses. From 2000 to 2005 Mr. Dick was Vice Chairman and Chief Financial Officer of Haverstick Consulting, Inc. located in Carmel, Indiana. Haverstick Consulting is a business and technology-consulting firm that is one of the fastest growing companies in Indiana. From 1986 to 2000 he was Executive Vice President and Chief Financial Officer of Conseco, Inc., a New York Stock Exchange financial services company with $100 billion of assets under management. In that role Mr. Dick worked closely with the Chief Executive Officer to plan and execute Conseco’s numerous acquisitions and financings in addition to normal CFO responsibilities. From 1965 to 1986, Mr. Dick was a partner at Coopers & Lybrand. In 1970, he opened the Indianapolis office for Coopers & Lybrand. From 1951 to 1965, Mr. Dick was an auditor with two smaller CPA firms in Des Moines. Rollie has been an active "angel" and "venture capital" investor and had interests in thirty businesses. He is a director of numerous companies and three venture capital funds. Mr. Dick is a Certified Public Accountant, a Chartered Life Underwriter, and a Chartered Financial Consultant. He received the Ernst and Young award as Entrepreneur of the Year for the support he provided new businesses.
Dr. David W. Crabb
Dr. David W. Crabb was appointed to the Board in the fall of 2006. Dr. Crabb received his B.S. in Biology from Purdue University and his M.D. from Indiana University. Starting in 2000, Dr. Crabb has been the Chairman of the Department of Medicine for Indiana University, having held various professorial positions with that department since 1983. His awards include membership in Phi Beta Kappa and Alpha Omega Alpha, the Marcus Ravdin Medal, the Bowman Prize for Biochemistry and Molecular Biology, and Outstanding Professor in Clinical Sciences. His professional memberships include, among others, a Master with the American College of Physicians, the American Society for Clinical Investigation, and the American Association of Physicians. Dr. Crabb is also a research scientist with a long list of peer-reviewed publications and current research projects, including a Center grant from the National Institute on Alcohol Abuse and Alcoholism (part of the National Institutes of Health), to investigate the role of genetics in alcoholism, and a grant studying treatmeants for alcoholic hepatitis.
Bruce R. Frank
Bruce R. Frank was elected to the board of directors in 2004. He serves on the Strategy and Audit Committees. Mr. Frank is the founder of a commercial consulting company, Bruce R. Frank & Associates. His company assists national and international companies, in a variety of industries, improve their ability to commercialize their technologies. Functional areas that BRF & Associates consults in range from strategy and business development to marketing and sales. His company is a culmination of Mr. Frank’s experience working at leading international companies. After playing professional basketball in Europe, he worked for McKinsey & Company in their Düsseldorf and Chicago offices, where he helped multinational companies optimize their business systems in the European market. Upon leaving the consulting industry, he worked at Baxter Travenol and Roche Diagnostics in various senior level positions in the US and internationally (Europe, Latin America and Asia). Mr. Frank also opened the US venture capital office of Quandt Holdings, a prominent German, industrial group. He graduated from the University of Pennsylvania with a BA in biology and the Wharton School with a MBA in finance.
James A. Strain
James A. Strain was elected to the Board of Directors in May 2001. He is co-chair of the Business and Finance Practice of Taft Stettinius & Hollister LLP and primarily practices in the areas of securities law, mergers and acquisitions and corporate governance. Before joining the firm in 1996, Mr. Strain was the Chairperson of the Business Department of Barnes & Thornburg where he had been a partner since January 1, 1976. Before joining the predecessor of Barnes & Thornburg in 1973, Mr. Strain had been law clerk to then Associate Justice William H. Rehnquist, October Term 1972, and before that to Judge John S. Hastings, then Senior Circuit Judge, United States Court of Appeals for the Seventh Circuit, 1970-71. Between his clerkships, he was an associate with Cahill, Gordon & Reindel in New York City. Mr. Strain was one of the architects of the Indiana Business Corporation Law and successfully defended its Control Shares Acquisition Chapter before the United States Supreme Court in CTS Corporation v. Dynamics Corporation of America. He has been recognized in the top tier of leading corporate/M&A lawyers in Indiana in Chambers USA: America’s Leading Lawyers for Business since it began its U.S. publication, has been named as a Super Lawyer in Indiana since its inception, and is the only M&A lawyer to have been named as one of the top 50 Super Lawyers in Indiana. He has been listed in The Best Lawyers in America for more than thirty years.
PTS, Inc. Named to Inc. 500/5000 Fastest Growing Private Companies for Third Time
PTS, Inc. Introduces CardioChek Plus Analyzer
PTS, Inc. Announces Two New Patents
PTS to Provide Point-of-Care Testing to Aegis Health Group's Hospital Clients
CardioChek®is FDA cleared and may be eligible for flexible spending account reimbursement.
©2013 Polymer Technology Systems, Inc. | 苏 ICP 备 11002895 号-2
Designed & Maintained by Shockoe Studios